Cargando…

Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis

Detalles Bibliográficos
Autor principal:	Bijlsma, Johannes W. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857790/ https://www.ncbi.nlm.nih.gov/pubmed/20407135 http://dx.doi.org/10.1093/rheumatology/keq056

Ejemplares similares

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

Patient benefit–risk in arthritis—a rheumatologist’s perspective
por: Bijlsma, Johannes W. J.
Publicado: (2010)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Balancing risk and benefit during coronavirus
por: Sehn, Laurie H.
Publicado: (2020)

NSAID choice: lessons from PRECISION
por: Reed, Grant W., et al.
Publicado: (2019)

NSAIDs, are they dangerous for pancreatic surgery?
por: Lee, Ji-Hyun
Publicado: (2022)

Prescription Pattern of NSAIDs and the Prevalence of NSAID-induced Gastrointestinal Risk Factors of Orthopaedic Patients in Clinical Practice in Korea
por: Lee, Sung-Hun, et al.
Publicado: (2011)

Use of NSAIDs in treating patients with arthritis
por: Crofford, Leslie J
Publicado: (2013)

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit
por: Ewer, Michael S, et al.
Publicado: (2016)

Balancing risks and benefits of artificial intelligence in the health sector
por: Goodman, Kenneth, et al.
Publicado: (2020)

Neurosurgical innovation: balancing the risks and benefits of technical novelty
por: Cohen-Gadol, Aaron A.
Publicado: (2019)

Benefit-risk balance of COVID drugs. New prospects
por: Cracowski, Jean-Luc, et al.
Publicado: (2022)

Treatment and chemoprevention of NSAID-associated gastrointestinal complications
por: Frech, Edward J, et al.
Publicado: (2009)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

Management of NSAID Associated Upper Gastrointestinal Problems
por: Cryer, Byron
Publicado: (2005)

Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
por: Hegazy, Ragia, et al.
Publicado: (2011)

Who is Who in Carbon Balance and Management 2006
por: Alexandrov, Georgii A
Publicado: (2007)

Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
por: Reid, David M.
Publicado: (2020)

Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
por: Singh, Shivani, et al.
Publicado: (2021)

Covid-19—The real role of NSAIDs in Italy
por: de Girolamo, Laura, et al.
Publicado: (2020)

Clinical Characteristics of NSAID-induced Blended Reaction
por: Hur, Gyu Young, et al.
Publicado: (2021)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

Balancing the benefits and harms of radiotherapy post-radical prostatectomy
por: Lamb, Benjamin W., et al.
Publicado: (2018)

Empiric Antibiotic Prescribing for Suspected Sepsis: A Stewardship Balancing Act
por: Pulia, Michael, et al.
Publicado: (2020)

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023)

The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits
por: Deen, Jacqueline
Publicado: (2016)

Improved percutaneous delivery of some NSAIDs for the treatment of arthritis
por: Thosani, Rushabh, et al.
Publicado: (2012)

Pain Treatment in Arthritis-Related Pain: Beyond NSAIDs
por: van Laar, Mart, et al.
Publicado: (2012)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Multicentre observational cohort study of NSAIDs as risk factors for postoperative adverse events in gastrointestinal surgery
por: Nepogodiev, Dmitri, et al.
Publicado: (2014)

NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study
por: Tachecí, Ilja, et al.
Publicado: (2013)

Individual NSAIDs and Upper Gastrointestinal Complications: A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)
por: Castellsague, Jordi, et al.
Publicado: (2012)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Pattern of Prescribing NSAIDs Utilisation at Outpatient Pediatric Poly at Universitas Sumatera Utara Hospital
por: Nasution, Embun Suci, et al.
Publicado: (2019)

A Potential Benefit of “Balanced Diet” for Rheumatoid Arthritis
por: Masuko, Kayo
Publicado: (2018)

Serum sodium changes in marathon participants who use NSAIDs
por: Whatmough, Steven, et al.
Publicado: (2018)

Assessment of Helicobacter pylori eradication in patients on NSAID treatment
por: Vonkeman, Harald E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v1if5vkd787lp77l9gglknqa2s